Melatonin receptor (MT1/MT2)
Assets acting on this target.
- Class
- Melatonin receptor agonist
- Notes
- mechanism wave 2026-08-24 (DeepSeek draft; registry text of NCT06489327 names the target); source: https://clinicaltrials.gov/study/NCT06489327
Related mechanisms
Melatonin receptor (MT1/MT2) drugs compared
2 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| tasimelteonHetlioz | Vanda Pharmaceuticals | small molecule | Approved | Approved in Non-24-Hour Sleep-Wake Disorder |
| Melatonin prolonged-releaseCircadin | Neurim Pharmaceuticals Ltd. | Not recorded | Phase 3 | Not recorded |